
Anthropic’s IPO pitch includes a warning about human extinction
Anthropic’s circulated S-1 spends heavily on risk factors—including existential harm—while backers eye a valuation north of $2 trillion.
Desk
Coverage tied to Anthropic and Claude.

Anthropic’s circulated S-1 spends heavily on risk factors—including existential harm—while backers eye a valuation north of $2 trillion.

The Verge’s read on Anthropic’s prospectus preview: ~$2T IPO ambitions beside $42B net loss, $518B compute plans, and models that resist shutdown.

TechCrunch digests the FT and Reuters S-1 leaks: grim model behaviors, existential-risk language, and a growth curve that still seduces a $2T listing dream.

Anthropic’s Sonnet 5.5 lands as a faster, thriftier mid-tier workhorse—about 30% quicker, with cyber safeguards usually reserved for higher tiers.

MIT Tech Review pushes back on Anthropic’s “first discovery” claim for a Claude-driven biology lab—pattern-finding isn’t the hard part of science.

TechCrunch previews a Disrupt 2026 session where Anthropic’s Cat de Jong, Gamma’s Grant Lee, and Clay dig into what happens after the AI demo ends.

Amodei’s first one-on-one with Trump lands the same weekend SNL roasted him—and after months of safety friction with the White House.

Equity’s take on Muse is sharper than the Connect keynote: party tricks land; handing Meta your cards and inbox is the real wall.

SNL turns Amodei’s doom-laden press tour into Gollum comedy—proof that AI safety talk has left the lab and entered late-night folklore.

A 2-1 D.C. Circuit panel let the Pentagon keep Anthropic blacklisted for withholding Claude features—no bad motive required under the broader supply-chain statute.

Anthropic’s $11.6B seven-year Akamai cloud deal bets on CPUs, not just GPUs—and flips the usual circular AI finance with warrants that grow as Anthropic spends.

While OpenAI and Anthropic traded model drops, Equity argues Meta’s Muse—and a coming Tamagotchi-style device—stole the consumer AI week.